first
report
septemb
middl
eastern
respiratori
syndrom
coronaviru
merscov
result
laboratoryconfirm
death
mortal
rate
march
close
relat
coronavirus
isol
bat
evid
suggest
human
becom
infect
directli
camel
number
separ
transmiss
event
limit
humantohuman
transmiss
report
thu
far
major
case
origin
middl
east
predominantli
saudi
arabia
includ
index
case
clinic
manifest
primarili
involv
fever
chill
rapidli
progress
respiratori
failur
often
result
acut
respiratori
distress
syndrom
minor
patient
report
gastrointestin
symptom
well
major
critic
ill
patient
older
male
medic
comorbid
larg
number
minim
symptomat
case
like
go
undetect
unfortun
attempt
therapi
unsuccess
thu
far
treatment
remain
support
care
first
introduct
medic
commun
would
later
call
middl
eastern
respiratori
syndrom
coronaviru
merscov
made
egyptian
microbiologist
ali
moham
zaki
promedmail
septemb
post
describ
previou
isol
june
coronaviru
sputum
identifi
pancoronaviru
revers
transcriptas
rt
pcr
assay
male
patient
acut
respiratori
renal
failur
unknown
etiolog
citi
jeddah
saudi
arabia
three
day
later
anoth
post
promedmail
appear
describ
male
qatari
nation
histori
travel
saudi
arabia
develop
similar
fulmin
symptom
respiratori
failur
london
hospit
case
gener
interest
regard
earlier
unsolv
outbreak
occur
march
april
zarqa
jordan
involv
patient
includ
health
care
worker
hcw
result
death
pcr
test
bank
sampl
later
confirm
case
merscov
infect
zaki
sent
sampl
ron
fouchier
virolog
laboratori
erasmu
univers
medic
center
rotterdam
netherland
studi
viru
name
novemb
hcov
human
coronaviru
emc
erasmu
medic
center
name
merscov
came
may
although
custom
name
diseas
geograph
locat
uncommon
name
without
controversi
mani
complain
stigmat
middl
east
march
laboratoryconfirm
case
merscov
infect
death
mortal
rate
detail
world
health
organ
merscov
summari
literatur
updat
median
age
infect
patient
year
signific
predomin
men
affect
malefemal
ratio
larg
major
patient
underli
comorbid
earlier
updat
merscov
research
group
common
vol
august
wwwcmnewslettercom
comorbid
chronic
kidney
diseas
follow
diabet
mellitu
heart
diseas
immunocompromis
statu
almost
patient
experienc
sever
respiratori
diseas
although
report
case
asymptomat
true
number
minim
symptomat
asymptomat
case
commun
like
much
greater
interestingli
stark
differ
found
primaryindex
case
secondari
case
primari
case
older
individu
averag
age
year
occur
predominantli
report
high
men
secondari
case
individu
averag
age
year
men
affect
addit
differ
sever
astound
primari
case
classifi
sever
fatal
diseas
oppos
secondari
case
affect
countri
middl
east
includ
kingdom
saudi
arabia
major
case
date
jordan
kuwait
oman
qatar
unit
arab
emir
addit
case
occur
european
countri
franc
germani
itali
unit
kingdom
well
african
countri
tunisia
recent
unit
state
european
us
african
case
either
import
middl
east
secondari
case
sinc
first
detect
case
march
april
zarqa
jordan
number
detect
case
increas
significantli
around
april
part
due
expans
aggress
screen
recommend
fall
saudi
arabian
ministri
health
moh
hospit
patient
fever
respiratori
symptom
also
close
contact
thu
far
evid
found
sustain
commun
transmiss
merscov
secondari
attack
rate
among
famili
member
low
nosocomi
spread
hcw
patient
reason
limit
cluster
among
famili
member
well
hospit
cluster
among
patient
hcw
report
number
countri
studi
cluster
allow
calcul
estim
incub
time
day
true
preval
diseas
difficult
estim
like
number
case
asymptomat
minim
symptomat
commun
went
unrecogn
especi
younger
healthier
patient
attempt
identifi
case
made
includ
larg
prospect
studi
memish
et
al
aim
widespread
screen
merscov
contact
saudi
arabia
use
pcr
respiratori
tract
sampl
period
start
septemb
individu
screen
detect
case
adult
children
case
detect
rate
approxim
total
popul
screen
major
posit
case
hospit
patient
suspect
infect
rest
almost
evenli
split
hcw
exposur
confirm
merscov
case
famili
contact
author
note
case
like
miss
given
serolog
use
screen
process
screen
resolv
infect
although
case
detect
rate
hcw
around
note
moh
saudi
arabia
aggress
infect
control
practic
includ
recommend
contact
airborn
precaut
earli
epidem
hajj
pilgrim
screen
attempt
identifi
minim
symptomat
asymptomat
case
commun
gautret
et
al
systemat
survey
french
pilgrim
return
hajj
saudi
arabia
pcr
test
nasal
swab
complet
prior
departur
franc
day
prior
return
although
greater
suffer
respiratori
symptom
hajj
pilgrimag
none
test
posit
merscov
suggest
low
transmiss
viru
notabl
averag
age
cohort
year
chronic
diseas
comorbid
includ
greater
diabet
mellitu
nosocomi
transmiss
occur
number
hospit
includ
german
hospit
present
buchholz
et
al
author
report
contact
investig
involv
larg
number
hcw
expos
patient
merscov
infect
support
notion
nosocomi
transmiss
merscov
limit
even
without
appropri
isol
precaut
person
protect
equip
index
patient
transfer
german
hospit
approxim
day
symptom
began
diagnos
merscov
infect
month
initi
admiss
qatar
author
identifi
contact
patient
underw
serolog
test
approach
notabl
specif
respiratori
precaut
taken
protect
measur
gener
limit
glove
occasion
gown
surgic
face
mask
suction
nine
hcw
perform
aerosolgener
procedur
within
week
patient
ill
notabl
none
contact
hcw
test
posit
merscov
transmiss
among
famili
member
nice
exemplifi
memish
et
al
present
famili
cluster
involv
patient
riyadh
saudi
arabia
novemb
index
case
male
diabet
mellitu
coronari
arteri
diseas
hypertens
develop
merscov
infect
manifest
acut
respiratori
renal
failur
die
hospit
day
two
son
smoker
contract
diseas
well
one
die
within
day
admiss
recov
pneumonialik
present
requir
intub
fourth
patient
healthi
grandson
index
patient
son
abovement
patient
die
recov
classifi
probabl
case
given
test
posit
pcr
ill
character
flulik
symptom
along
diarrhea
abdomin
pain
imag
reveal
bilater
hilar
infiltr
made
full
recoveri
patient
live
among
total
famili
member
within
larg
hous
mostli
separ
apart
famili
includ
children
author
nice
detail
amount
contact
among
famili
member
gener
famili
member
ill
note
men
adolesc
male
share
meal
social
worship
togeth
notabl
separ
wive
children
index
patient
becam
ill
tend
home
women
household
son
becam
ill
howev
hospit
wive
rare
visit
son
continu
tend
father
fell
ill
similarli
wive
children
limit
contact
male
patient
hospit
fact
women
children
becom
ill
suggest
infect
may
limit
earli
cours
ill
notabl
none
famili
member
develop
respiratori
symptom
period
assiri
et
al
review
laboratoryconfirm
case
merscov
diseas
report
kingdom
saudi
arabia
septemb
june
case
includ
cluster
one
involv
peopl
resid
villa
compris
case
hospit
outbreak
alhasa
region
saudi
arabia
none
patient
concomit
blood
respiratori
viral
fungal
bacteri
infect
major
receiv
oseltamivir
broadspectrum
antibiot
includ
coverag
atyp
bacteria
case
fatal
rate
among
cohort
split
evenli
male
femal
comorbid
medic
disord
found
vast
major
patient
common
comorbid
disord
includ
diabet
mellitu
onethird
patient
chronic
kidney
diseas
almost
half
hypertens
chronic
heart
diseas
one
patient
longterm
immunosuppress
steroid
author
note
import
factor
regard
statist
first
diabet
common
saudi
arabian
citizen
age
year
second
alhasa
outbreak
involv
hemodialysi
unit
therebi
inflat
number
patient
chronic
kidney
diseas
predomin
present
symptom
cohort
patient
fever
chill
rigor
cough
slightli
half
dri
rest
product
dyspnea
less
common
present
symptom
includ
myalgia
diarrhea
nausea
vomit
patient
requir
intens
care
requir
mechan
ventil
median
time
ventil
day
death
day
common
laboratori
abnorm
includ
elev
lactat
dehydrogenas
roughli
half
thrombocytopenia
lymphopenia
hepat
abnorm
uncommon
elev
aspart
transaminas
elev
alanin
aminotransferas
patient
abnorm
chest
x
ray
mani
differ
pattern
observ
includ
patchi
infiltr
interstiti
chang
consolid
nodular
reticular
opac
pleural
effus
limit
experi
survivor
rehabilit
phase
reveal
prolong
weak
dyspnea
occasion
anxieti
depress
pulmonari
lung
function
test
complet
month
hospit
discharg
reveal
mild
moder
restrict
pattern
note
cohort
patient
like
repres
merscovinfect
popul
whole
recommend
saudi
arabian
moh
aggress
screen
inpati
fever
respiratori
ill
led
diagnosi
mani
case
among
older
patient
mani
comorbid
second
cohort
includ
patient
involv
larg
hospit
outbreak
intensivecar
unit
andor
hemodialysi
prior
becom
infect
merscov
addit
laboratori
abnorm
note
seri
includ
anemia
hyponatremia
hypoalbuminemia
elev
creactiv
protein
procalcitonin
level
organ
dysfunct
includ
pericard
dissemin
intravascular
coagul
marker
renal
function
blood
urea
nitrogen
creatinin
level
gener
avail
larg
publish
cohort
recent
summari
statement
note
sever
case
develop
renal
failur
clinic
cours
number
patient
merscov
infect
develop
bacteri
superinfect
gramposit
gramneg
organ
well
patient
viral
pulmonari
coinfect
includ
influenza
viru
infect
type
parainfluenza
payn
et
al
publish
case
secondtrimest
stillbirth
pregnant
subject
merscov
infect
confirm
serolog
method
patient
jordanian
femal
close
contact
case
one
die
merscov
infect
develop
acut
respiratori
symptom
concurr
vagin
bleed
abdomin
pain
follow
deliveri
stillborn
fetu
although
author
abl
demonstr
associ
merscov
stillbirth
causal
suggest
biolog
plausibl
well
advers
birth
outcom
note
sever
acut
respiratori
syndrom
sar
influenza
viru
epidem
merscov
envelop
positivesens
singlestrand
rna
viru
order
nidoviral
famili
coronavirida
genu
betacoronaviru
lineag
c
clade
coronaviru
genera
alphacoronaviru
betacoronaviru
gammacoronaviru
deltacoronaviru
genu
alphacoronaviru
contain
caus
common
cold
genu
betacoronaviru
contain
coronavirus
caus
common
cold
sarscov
merscov
common
bat
coronavirus
notabl
coronavirus
account
respiratori
infect
roughli
gener
popul
antibodi
coronavirus
infect
larg
number
anim
includ
livestock
poultri
bat
camel
pet
human
horsesho
bat
found
natur
reservoir
sar
coronaviru
make
bat
reason
place
start
search
like
anim
host
merscov
woo
et
al
perform
coronaviru
surveil
studi
bat
hong
kong
special
administr
region
found
differ
novel
coronavirus
among
speci
bat
region
alon
find
sarscov
origin
merscov
may
origin
bat
surpris
given
number
factor
investig
note
bat
behavior
includ
abil
fli
high
meter
roost
larg
number
bat
annan
et
al
found
juvenil
lactat
femal
bat
much
like
harbor
coronavirus
adult
nonlact
femal
argu
bat
matern
coloni
like
play
role
amplif
coronavirus
addit
given
bat
speci
becom
infect
multipl
speci
coronavirus
factor
facilit
viral
genet
exchang
among
coronavirus
bat
speci
anim
given
coronavirus
high
frequenc
recombin
high
mutat
rate
infect
bat
creat
perfect
storm
creation
novel
coronavirus
adapt
infect
human
search
proceed
earnest
bat
coronavirus
similar
genet
ident
merscov
asia
search
target
common
bat
coronavirus
lesser
bamboo
bat
tylonycteri
pachypu
japanes
hous
bat
pipistrellu
abramu
repres
known
coronavirus
betacoronaviru
clade
along
merscov
lau
et
al
found
speci
approxim
sequenc
overlap
portion
rna
polymeras
gene
rdrp
even
less
sequenc
n
gene
conclud
neither
coronavirus
like
direct
ancestor
merscov
like
diverg
number
centuri
ago
common
ancestor
annan
et
al
target
bat
speci
ghana
well
countri
europ
germani
netherland
romania
ukrain
also
use
rdrp
gene
target
found
novel
coronavirus
betacoronaviru
clade
region
world
one
novel
coronaviru
isol
common
pipistrel
bat
pipistrellu
pipistrellu
differ
merscov
amino
acid
ident
south
africa
ithet
et
al
discov
novel
betacoronaviru
adult
femal
neoromicia
zuluensi
bat
differ
merscov
amino
acid
exchang
translat
rdrp
gene
fragment
author
note
coronaviru
close
relat
merscov
known
coronavirus
includ
found
ghana
abovement
coronavirus
asia
suggest
african
origin
merscov
closest
coronaviru
ancestor
camel
hypothes
primari
reservoir
merscov
number
intrigu
studi
clearli
demonstr
camel
infect
viru
suggest
clearli
prove
direct
cameltohuman
transmiss
reusken
et
al
provid
evid
infect
merscov
mean
posit
serolog
cohort
dromedari
camel
one
oman
canari
island
spain
omani
camel
test
posit
satur
reactiv
microarray
high
merscovneutr
capac
contrast
spanish
camel
display
neutral
capac
author
note
cohort
relat
spanish
camel
import
africa
centuri
time
import
africa
region
ban
wherea
omani
camel
like
import
africa
much
later
merscov
introduc
cohort
whether
distant
connect
remain
unclear
similarli
perera
et
al
found
seropreval
rate
greater
dromedari
camel
egypt
use
novel
spike
pseudoparticl
neutral
assay
saudi
arabia
alagaili
et
al
perform
nationwid
survey
dromedari
camel
use
serolog
molecular
diagnost
method
found
camel
survey
antibodi
merscov
elisa
western
blot
confirm
addit
found
juvenil
camel
adult
camel
pcr
posit
primarili
nasal
swab
method
rectal
swab
none
serum
whole
blood
sampl
posit
author
argu
isol
viru
primarili
nasal
secret
suggest
airborn
rout
transmiss
addit
author
test
number
sampl
camel
archiv
sinc
major
posit
sampl
avail
year
limit
asid
camel
test
posit
suggest
merscov
circul
camel
sinc
least
final
number
camel
resid
small
farm
qatar
link
case
human
merscov
infect
part
outbreak
investig
octob
patient
regular
contact
anim
farm
includ
camel
neither
recent
travel
outsid
qatar
prior
becom
ill
six
camel
test
posit
merscov
nasal
swab
pcr
assay
meet
intern
criterion
pcr
test
must
posit
camel
antibodi
posit
immunofluoresc
neutral
capac
sequenc
perform
reveal
differ
open
read
frame
region
camel
human
case
differ
camel
earli
human
isol
erasmu
medic
center
laboratori
rotterdam
netherland
note
author
provid
evid
merscov
infect
camel
delin
cameltohuman
versu
humantocamel
transmiss
camel
human
independ
infect
third
sourc
bat
number
recent
studi
identifi
human
target
merscov
organ
affect
specif
cellular
receptor
spike
protein
merscov
bind
chan
et
al
studi
abil
merscov
infect
differ
human
anim
cell
line
vitro
infect
cell
line
includ
human
cell
line
criteria
infect
merscov
includ
measur
mean
viral
load
higher
baselin
level
rtpcr
express
nucleoprotein
immunofluoresc
demonstr
cytopath
effect
result
show
human
cell
line
met
criteria
includ
cell
lower
airway
kidney
intestin
tract
liver
well
histiocyt
find
correl
clinic
find
sever
pulmonari
diseas
patient
acut
renal
injuri
gastrointestin
symptom
mild
hepat
note
minor
patient
notabl
merscov
infect
upper
airway
cell
line
interestingli
merscov
abl
infect
primat
pig
civet
cat
cell
line
author
infect
criteria
met
canin
felin
rodent
chicken
insect
cell
line
similarli
muller
et
al
infect
number
anim
cell
line
merscov
note
bat
cell
line
test
readili
infect
chan
et
al
util
fresh
biopsi
specimen
human
bronchi
lung
parenchyma
demonstr
quantifi
infect
merscov
also
use
sarscov
common
human
coronaviru
control
group
human
bronchial
specimen
util
viral
antigen
stain
rtpcr
target
region
upstream
e
gene
detect
increas
merscov
within
hour
infect
notabl
sarscov
infect
tissu
without
signific
increas
viral
titer
baselin
lung
parenchym
tissu
detect
signific
amount
merscov
antigen
throughout
lung
increas
within
hour
infect
result
similar
sarscov
infect
contrast
coronaviru
infect
either
bronchial
lung
parenchym
tissu
next
author
use
immunohistochem
method
cellular
stain
specif
cell
marker
electron
microscopi
identifi
merscov
antigen
specif
cell
bronchi
lung
parenchyma
vessel
lung
merscov
notabl
local
noncili
bronchiolartyp
epitheli
cell
bronchi
type
type
ii
pneumocyt
epitheli
cell
within
lung
parenchyma
final
endotheli
cell
within
mediums
interstiti
vessel
lung
notabl
cell
stain
includ
macrophag
ciliat
cell
lung
goblet
cell
author
postul
infect
endotheli
cell
mediums
interstiti
vessel
may
provid
mean
extrapulmonari
dissemin
direct
indirect
use
transmiss
electron
microscopi
along
stain
extens
express
cleav
caspas
proteas
heavili
involv
apoptosi
well
merscov
antigen
differ
color
demonstr
extens
apoptosi
note
apoptot
cell
differ
cell
express
viral
protein
base
lack
costain
suggest
paracrin
mechan
apoptosi
rather
direct
infect
raj
et
al
abl
identifi
cellular
receptor
merscov
bind
known
dipeptidyl
peptidas
gener
coronavirus
bind
host
cell
surfac
receptor
use
specif
domain
spike
entri
protein
sarscov
use
metallopeptidas
angiotensinconvert
enzym
type
ii
transmembran
glycoprotein
present
cell
surfac
mani
function
includ
role
glucos
metabol
cell
activ
chemotaxi
modul
cell
adhes
apoptosi
primari
site
express
human
includ
kidney
small
intestin
liver
prostat
epitheli
cell
well
activ
leukocyt
investig
prove
hypothesi
number
method
use
cell
line
includ
vero
human
liver
cell
method
includ
inhibit
vero
cell
infect
solubl
blockag
infect
cell
preincub
polyclon
antiserum
viru
inocul
final
transform
previous
nonsuscept
cell
cell
capabl
merscov
infect
transfect
human
express
plasmid
addit
demonstr
number
common
coronavirus
includ
unabl
infect
human
cell
express
primari
mean
test
merscov
infect
rtpcr
posit
bronchoalveolar
lavag
nasopharyng
aspir
sputum
tracheal
aspir
urin
specimen
laboratoryconfirm
case
defin
either
two
posit
pcr
assay
differ
target
one
posit
pcr
assay
along
one
posit
pcr
sequenc
product
usual
rdrp
gene
target
corman
et
al
develop
two
earli
rtpcr
test
use
rotterdam
viru
isol
ron
fouchier
laboratori
templat
one
target
upstream
region
e
protein
gene
upe
target
section
orf
term
crossreact
either
assay
four
common
human
respiratori
coronavirus
sarscov
larg
number
common
respiratori
virus
includ
parainfluenza
serotyp
respiratori
syncyti
viru
rsv
human
metapneumoviru
influenza
viru
addit
rtpcr
assay
develop
includ
nucleocapsid
n
spike
gene
target
upe
assay
consid
highli
sensit
assay
less
upe
assay
recommend
screen
follow
use
assay
confirm
serum
neutral
antibodi
titer
also
help
identifi
past
infect
expect
rise
fourfold
taken
day
apart
buchholz
et
al
util
twostag
serolog
approach
screen
contact
investig
first
use
indirect
immunofluoresc
assay
ifa
broad
screen
follow
confirm
recombin
ifa
serum
neutral
test
growth
viral
cultur
variou
specimen
includ
respiratori
fecal
urin
tissu
demonstr
practic
particip
laboratori
would
requir
biosafeti
level
precaut
infect
variou
cell
line
includ
vero
cell
produc
cytopath
effect
includ
syncytium
format
two
group
investig
independ
infect
rhesu
macaqu
merscov
first
intratrach
second
varieti
rout
yao
et
al
report
juvenil
rhesu
macaqu
age
year
demonstr
transient
increas
bodi
temperatur
decreas
water
intak
well
signific
chang
lung
imag
x
ray
reveal
local
infiltr
interstiti
mark
autopsi
find
show
congest
scatter
nodul
microscop
multifoc
interstiti
pneumonia
exud
chang
interestingli
extrapulmonari
lesion
observ
includ
within
kidney
despit
observ
moder
incid
renal
failur
human
infect
pcr
notabl
posit
lung
homogen
neg
oropharyng
nasal
cloacal
swab
addit
organ
neutral
antibodi
appear
day
infect
peak
day
none
infect
monkey
die
munster
et
al
perform
similar
experi
use
older
monkey
age
year
report
find
reduc
appetit
cough
tachypnea
piloerect
hunch
postur
well
serum
laboratori
result
includ
leukocytosi
addit
patholog
result
includ
multifoc
coalesc
bright
red
lesion
throughout
lower
respiratori
tract
progress
dark
reddish
purpl
fibrou
adhes
consolid
edemat
atelectat
area
lung
attempt
develop
smallanim
model
would
provid
easier
less
expens
mean
studi
viru
use
primat
unsuccess
primarili
due
lack
receptor
mani
smallanim
speci
although
mani
research
consider
difficulti
infect
mice
hamster
guinea
pig
ferret
merscov
zhao
et
al
creat
mous
model
mean
transduct
recombin
nonrepl
adenoviru
express
receptor
abl
success
use
model
studi
clinic
diseas
also
possibl
therapi
potenti
vaccin
moh
saudi
arabia
aggress
infect
control
effort
proactiv
surveil
possibl
contact
confirm
merscov
case
soon
first
case
report
merscov
infect
septemb
saudi
arabia
moh
recommend
aggress
screen
inpati
unexplain
respiratori
symptom
well
activ
screen
contact
lead
increas
case
detect
rate
includ
asymptomat
minim
symptomat
case
moh
also
target
hajj
event
could
lead
potenti
epidem
involv
larg
number
peopl
gather
around
world
close
proxim
control
measur
implement
includ
recommend
wear
mask
overcrowd
area
elderli
chronic
diseas
includ
diabet
kidney
diseas
immunodefici
cancer
termin
ill
well
pregnant
women
children
postpon
trip
hajj
umrah
us
cdc
agre
advic
us
travel
european
cdc
agre
travel
restrict
howev
public
health
agenc
unanim
recommend
protect
measur
aim
limit
spread
respiratori
virus
among
religi
pilgrim
includ
cough
etiquett
wear
face
mask
although
clearli
effect
treatment
yet
develop
merscov
number
agent
shown
promis
vitro
treatment
option
current
limit
support
care
includ
mechan
ventil
respiratori
failur
andor
hemodialysi
set
renal
failur
extracorpor
membran
oxygen
attempt
least
patient
surviv
corticosteroid
use
prevent
progress
adult
respiratori
distress
syndrom
fibrot
stage
benefit
practic
unclear
interferon
alpha
ribavirin
postul
treat
merscov
infect
given
role
treatment
virus
hepat
c
viru
rsv
lassa
fever
viru
ribavirin
nucleosid
analog
inhibit
rna
replic
wide
spectrum
antivir
activ
falzarano
et
al
design
experiment
model
use
infect
vero
cell
test
effect
ribavirin
interferon
defin
marker
treatment
success
includ
reduct
number
viral
genom
copi
cytopath
effect
dosedepend
reduct
genom
copi
note
interferon
reach
reduct
uml
ribavirin
reach
reduct
gml
similar
success
note
regard
reduct
cytopath
effect
elimin
uml
interferon
ribavirin
howev
author
note
concentr
like
safe
achiev
human
two
drug
combin
though
abl
achiev
decreas
dose
requir
make
theoret
possibl
achiev
therapeut
level
human
two
small
studi
detail
treatment
merscov
infect
interferon
ribavirin
human
rhesu
macaqu
altawfiq
et
al
present
retrospect
observ
studi
patient
treat
ribavirin
interferon
alpha
none
respond
treatment
notabl
patient
advanc
age
averag
age
year
signific
comorbid
treatment
start
day
admiss
due
part
difficulti
diagnosi
contrast
falzarano
et
al
demonstr
promis
result
infect
rhesu
macaqu
treatment
combin
demonstr
improv
pulmonari
edema
decreas
serum
pulmonari
proinflammatori
marker
reduct
viral
genom
copi
result
may
quit
difficult
replic
infect
human
howev
treatment
start
hour
inocul
viru
convalesc
sera
patient
recov
sarscov
infect
also
postul
benefici
role
treatment
merscov
infect
southern
china
chan
et
al
measur
compar
level
merscov
antibodi
recov
sar
patient
anim
handler
includ
anim
market
retail
slaughter
chicken
duck
gees
pigeon
rabbit
cat
etc
use
highrisk
surrog
coronaviru
infect
healthi
blood
donor
significantli
higher
number
sar
patient
antimerscov
immunoglobulin
g
indirect
immunofluoresc
test
titer
rang
compar
anim
handler
titer
none
healthi
blood
donor
use
neutral
antibodi
test
author
found
sar
patient
low
merscov
neutral
antibodi
titer
less
comparison
none
anim
handler
healthi
blood
donor
result
support
hypothet
role
convalesc
sera
recov
sar
patient
provid
degre
activ
antibodi
suggest
intraven
immunoglobulin
healthi
donor
may
help
anoth
option
along
line
use
convalesc
serum
recov
merscov
patient
tri
serum
recov
sar
patient
question
success
sarscov
epidem
also
known
function
receptor
merscov
bronchiolar
tissu
put
therapeut
target
inhibit
bind
merscov
inhibitor
sitagliptin
vildagliptin
saxagliptin
current
use
treatment
diabet
mellitu
unabl
block
bind
merscov
receptor
vitro
posit
side
adenosin
deaminas
natur
ligand
shown
inhibit
merscov
infect
ferret
transfect
human
human
monoclon
polyclon
antibodi
shown
promis
use
vitro
studi
idea
treatment
includ
develop
fusion
inhibitor
compound
would
block
subunit
spike
protein
mediat
membran
fusion
host
target
cell
promis
therapeut
compound
develop
lu
et
al
develop
peptid
inhibit
replic
fusion
merscov
anoth
promis
develop
abil
cyclophilin
inhibitor
mycophenol
acid
cyclosporin
block
replic
merscov
rna
vitro
vaccin
design
earli
development
stage
base
earlier
vaccin
candid
sarscov
design
target
receptorbind
domain
compon
spike
protein
sinc
first
case
merscov
infect
identifi
retrospect
zarqa
jordan
approxim
year
ago
viru
affect
patient
kill
progress
made
diagnos
infect
limit
nosocomi
spread
clearli
effect
treatment
yet
exist
remain
seen
viru
disappear
human
sarscov
gain
increas
transmiss
lead
worldwid
pandem
